| Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD F Bibbiani, JD Oh, A Kielaite, MA Collins, C Smith, TN Chase Experimental neurology 196 (2), 422-429, 2005 | 154 | 2005 |
| Label-Free LC–MS/MS proteomic analysis of cerebrospinal fluid identifies Protein/Pathway alterations and candidate biomarkers for amyotrophic lateral sclerosis MA Collins, J An, BL Hood, TP Conrads, RP Bowser Journal of proteome research 14 (11), 4486-4501, 2015 | 98 | 2015 |
| The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions … M Collins, D Riascos, T Kovalik, J An, K Krupa, K Krupa, BL Hood, ... Acta neuropathologica 124, 717-732, 2012 | 87 | 2012 |
| Total protein is an effective loading control for cerebrospinal fluid western blots MA Collins, J An, D Peller, R Bowser Journal of neuroscience methods 251, 72-82, 2015 | 76 | 2015 |
| Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein–protein interaction network Y Li, M Collins, J An, R Geiser, T Tegeler, K Tsantilas, K Garcia, P Pirrotte, ... Brain research 1647, 79-93, 2016 | 62 | 2016 |
| RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules Y Li, M Collins, R Geiser, N Bakkar, D Riascos, R Bowser Scientific reports 5 (1), 1-15, 2015 | 34 | 2015 |
| Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates CPS Smith, JD Oh, F Bibbiani, MA Collins, I Avila, TN Chase Neuropharmacology 52 (2), 515-526, 2007 | 24 | 2007 |
| RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases M Collins, Y Li, R Bowser Acta neuropathologica communications 8, 1-25, 2020 | 17 | 2020 |
| Molecular Mechanisms of Amyotrophic Lateral Sclerosis M Collins, R Bowser Molecular and Cellular Therapies for Motor Neuron Diseases, 61-99, 2017 | 4 | 2017 |
| Substrate-specific effects of natural genetic variation on proteasome activity MA Collins, R Avery, FW Albert PLoS genetics 19 (5), e1010734, 2023 | 2 | 2023 |
| Variation in ubiquitin system genes creates substrate-specific effects on proteasomal protein degradation MA Collins, G Mekonnen, FW Albert Elife 11, e79570, 2022 | 2 | 2022 |
| Identification of amyotrophic lateral sclerosis disease mechanisms by cerebrospinal fluid proteomic profiling M Collins University of Pittsburgh, 2016 | 2 | 2016 |
| Nuclear stress response in motor neuron disease and other neurological diseases R Bowser, M Collins US Patent 9,983,217, 2018 | 1 | 2018 |
| Variation in Ubiquitin System Genes Creates Substrate-Specific Effects on Proteasomal Protein Degradation MA Collins, G Mekonnen, FW Albert bioRxiv, 2021.05. 05.442832, 2022 | | 2022 |
| Nuclear stress response in motor neuron disease and other neurological diseases R Bowser, M Collins US Patent 10,359,436, 2019 | | 2019 |
| The Effects of Systemic and Locally Administered Glutamatergic Antagonists on Parkinsonian Non-motor Symptoms MA Collins Central Michigan University, 2008 | | 2008 |
| Genetic Basis of Variation in Ubiquitin-Proteasome System MA Collins, G Mekonnen, FW Albert, MA Collins, FW Albert | | |
| Substrate-Specific Effects of Natural Genetic Variation on Proteasome MA Collins, RR Avery, FW Albert | | |
